Clinical experience with platelet-activating factor antagonists. Past, present, and near future.
Guinot
P
P
University of California, Department of Internal Medicine, School of Medicine, Davis 95616-8660, USA.
D000818:Animals; D001381:Azepines / Q000494:pharmacology; D002986:Clinical Trials as Topic; D006084:Graft Rejection / Q000188:drug therapy; D006801:Humans; D016030:Kidney Transplantation; D007783:Lactones; D010936:Plant Extracts / Q000494:pharmacology; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors*; D016032:Randomized Controlled Trials as Topic; D012772:Shock, Septic / Q000188:drug therapy; D058924:Thienopyridines; D014230:Triazoles / Q000494:pharmacology
D001381:Azepines; D007783:Lactones; D010936:Plant Extracts; D010972:Platelet Activating Factor; D058924:Thienopyridines; D014230:Triazoles; C050422:BN 52063; C066686:BN 50730; C067429:Setipafant